← Open Payments lookup

BRAD BURGESS: Open Payments

NPI 1285193458 · PITTSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,025 in 45 payments from 11 companies in 2025. Trend: 2023 $160 · 2024 $262 · 2025 $1,025

Food & beverage: $1,025
CompanyPaymentsAmount
Alkermes, Inc.10$182
Neurocrine BioSciences, Inc.7$173
Vanda Pharmaceuticals Inc.3$164
Otsuka America Pharmaceutical, Inc.8$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$78
E.R. Squibb & Sons, L.L.C.3$75
Janssen Pharmaceuticals, Inc3$71
ABBVIE INC.3$47
Teva Pharmaceuticals USA, Inc.2$32
Takeda Pharmaceuticals U.S.A., Inc.2$32

Products named: INGREZZA, FANAPT, REXULTI, ARISTADA, CAPLYTA, VIVITROL, COBENFY, SPRAVATO.

Industry payments across MA — which companies pay providers there.